Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Cellular immunity in acne vulgaris during transfer factor treatment.

Ashorn R, Uotila A, Kuokkanen K, Räsänen L, Karhumäki E, Krohn K.

Ann Clin Res. 1985;17(4):152-5.

PMID:
2934019
2.

The effect of transfer factor on cystic acne.

Gröhn P, Kuokkanen K, Krohn K.

Acta Derm Venereol. 1978;58(2):153-5.

PMID:
76396
3.

Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.

Schut BJ, Dooren LJ, Uittenbogaart CH, Schellekens PT, Eijsvoogel VP.

Immunology. 1979 Jan;36(1):1-12.

4.

No effect of transfer factor in juvenile rheumatoid arthritis by double-blind trial.

Høyeraal HM, Frøland SS, Salvesen CF, Munthe E, Natvig JB, Kåss E, Blichfeldt P, Hegna TM, Revlem E, Sandstad B, Hjort NL.

Ann Rheum Dis. 1978 Apr;37(2):175-9.

5.
6.

Cell mediated immunity in patients with Virchowian hanseniasis before and after treatment with transfer factor.

Leser PG, Margarido L, Belda W, Sartori SG, Hares WA, Freire CA, Fleury R, Montenegro MR, Leser W, Naspitz CK.

Hansenol Int. 1980 Jun;5(1):3-27.

PMID:
7042563
7.

A pilot study on efficacy treatment of acne vulgaris using a new method: results of a randomized double-blind trial with Acne Dressing.

Chao CM, Lai WY, Wu BY, Chang HC, Huang WS, Chen YF.

J Cosmet Sci. 2006 Mar-Apr;57(2):95-105.

PMID:
16688374
8.

Lymphocyte transformation in subjects with nodulo cystic acne.

Puhvel SM, Amirian D, Weintraub J, Reisner RM.

Br J Dermatol. 1977 Aug;97(2):205-11.

PMID:
143951
9.

Delayed hypersensitivity to Propionibacterium acnes in patients with severe nodular acne and acne fulminans.

Karvonen SL, Räsänen L, Cunliffe WJ, Holland KT, Karvonen J, Reunala T.

Dermatology. 1994;189(4):344-9.

PMID:
7873817
10.

Cellular immunity to P. acnes in the normal population and patients with acne vulgaris.

Gowland G, Ward RM, Holland KT, Cunliffe WJ.

Br J Dermatol. 1978 Jul;99(1):43-7.

PMID:
150284
11.

Clinical evaluation in acne.

Lidén S, Göransson K, Odsell L.

Acta Derm Venereol Suppl (Stockh). 1980;Suppl 89:47-52.

PMID:
6451126
12.
13.

[Immunomodulating and therapeutic effects of the STAVA inj. preparation in acne vulgaris].

Jautová J, Jarcusková D, Ficová M, Dubivská M.

Epidemiol Mikrobiol Imunol. 1995 Mar;44(1):29-32. Slovak.

PMID:
7757346
14.

Transfer factor therapy in patients with cancer.

Vetto RM, Burger DR, Nolte JE, Vandenbark AA, Baker HW.

Cancer. 1976 Jan;37(1):90-7.

15.

Photopneumatic technology for the treatment of acne vulgaris.

Shamban AT, Enokibori M, Narurkar V, Wilson D.

J Drugs Dermatol. 2008 Feb;7(2):139-45.

PMID:
18335650
16.

Transfer factor in the treatment of chronic mucocutaneous candidiasis: a controlled study.

Mobacken H, Hanson LA, Lindholm L, Ljunggren C.

Acta Derm Venereol. 1980;60(1):51-5.

PMID:
6153834
17.
18.

[Treatment of acne with a yeast preparation].

Weber G, Adamczyk A, Freytag S.

Fortschr Med. 1989 Sep 10;107(26):563-6. German.

PMID:
2530145
19.

Meclosorb, a new topical antibiotic agent in the treatment of acne vulgaris: a double-blind clinical study.

Hjorth N, Schmidt H, Thomsen K, Dela K.

Acta Derm Venereol. 1984;64(4):354-7.

PMID:
6209900
20.

Transfer factor in Hodgkin's disease: a randomized clinical and immunological study.

Hancock BW, Bruce L, Sokol RJ, Clark A.

Eur J Cancer Clin Oncol. 1988 May;24(5):929-33.

PMID:
3049116

Supplemental Content

Support Center